Overview

Clinical Trial to Study the Safety Tolerability, Pharmacokinetics, Food Effect & Pharmacodynamics of a New Compound P7435 in Healthy, Overweight and/or Obese Subjects

Status:
Terminated
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
Clinical trial to study the safety tolerability, pharmacokinetics, food effect and pharmacodynamics of a new compound P7435 in in healthy, overweight and/or obese subjects
Phase:
Phase 1
Details
Lead Sponsor:
Piramal Enterprises Limited